Androgens are steroid hormones that are involved in sexual differentiation and prostate cancer progression in men, and the androgen receptor (AR) is a clinical target in androgen-dependent and castration-resistant prostate cancer (Shafi et al., 2013). This evidence concerns the gene AR and prostate carcinoma.